- Home
- CDLX vs AMRN Comparison
CDLX vs AMRN Comparison
Compare CDLX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDLX | AMRN |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.5M | 339.8M |
| IPO Year | 2018 | 1993 |
Fundamental Metrics
Financial Performance| Metric | CDLX | AMRN |
|---|---|---|
| Price | $1.19 | $14.14 |
| Analyst Decision | Hold | Strong Sell |
| Analyst Count | 3 | 1 |
| Target Price | $2.25 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 812.1K | 87.4K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,175,000.00 | $226,733,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.85 | $7.08 |
| 52 Week High | $4.05 | $20.90 |
Technical Indicators
Market Signals| Indicator | CDLX | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 48.52 | 41.21 |
| Support Level | $0.95 | $13.50 |
| Resistance Level | $1.24 | $14.30 |
| Average True Range (ATR) | 0.09 | 0.75 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 77.19 | 25.43 |
Price Performance
Historical ComparisonAbout CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.